Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Double trouble for Langerhans cell histiocytosis.

  • Read more about Double trouble for Langerhans cell histiocytosis.

The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.

  • Read more about The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

  • Read more about A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

Tumor Thrombus- a Single Center Experience with Tumor Thrombus and Role of Anticoagulation

  • Read more about Tumor Thrombus- a Single Center Experience with Tumor Thrombus and Role of Anticoagulation

Response of Patients with Transfusion-Dependent ß-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for ß-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers.

  • Read more about Response of Patients with Transfusion-Dependent ß-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for ß-Thalassemia) Gene Therapy Based on HBB Genotype and Disease Genetic Modifiers.

Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with ß-Thalassemia in the Believe Trial.

  • Read more about Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with ß-Thalassemia in the Believe Trial.

Sex Based Differences in Sickle Cell Disease.

  • Read more about Sex Based Differences in Sickle Cell Disease.

Clinical Benefit and Tolerability of Crenolanib in Children with Relapsed Acute Myeloid Leukemia Harboring Treatment Resistant FLT3 ITD and Variant FLT3 TKD Mutations Treated on Compassionate Access.

  • Read more about Clinical Benefit and Tolerability of Crenolanib in Children with Relapsed Acute Myeloid Leukemia Harboring Treatment Resistant FLT3 ITD and Variant FLT3 TKD Mutations Treated on Compassionate Access.

Genetic Alterations Precede DNA Methylation Changes in Juvenile Myelomonocytic Leukemia.

  • Read more about Genetic Alterations Precede DNA Methylation Changes in Juvenile Myelomonocytic Leukemia.

Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome.

  • Read more about Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome.

Pagination

  • Previous page ‹‹
  • Page 8
  • Next page ››
Subscribe to Blood

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List